[go: up one dir, main page]

AR003476A1 - Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol - Google Patents

Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol

Info

Publication number
AR003476A1
AR003476A1 ARP960103957A AR10395796A AR003476A1 AR 003476 A1 AR003476 A1 AR 003476A1 AR P960103957 A ARP960103957 A AR P960103957A AR 10395796 A AR10395796 A AR 10395796A AR 003476 A1 AR003476 A1 AR 003476A1
Authority
AR
Argentina
Prior art keywords
tramadol
binder
salt
tablets containing
free tablets
Prior art date
Application number
ARP960103957A
Other languages
English (en)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR003476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR003476A1 publication Critical patent/AR003476A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se describen tabletas rápidamente disgregables y exentas de aglutinante que contienen tramadol o una sal de tramadol, para administración oral, y que secaracterizan por contener celulosa microcristalina.
ARP960103957A 1995-08-19 1996-08-12 Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol AR003476A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19530575A DE19530575A1 (de) 1995-08-19 1995-08-19 Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz

Publications (1)

Publication Number Publication Date
AR003476A1 true AR003476A1 (es) 1998-08-05

Family

ID=7769912

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103957A AR003476A1 (es) 1995-08-19 1996-08-12 Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol

Country Status (28)

Country Link
US (1) US5776492A (es)
EP (1) EP0759296B1 (es)
JP (1) JP4074675B2 (es)
CN (1) CN1102385C (es)
AR (1) AR003476A1 (es)
AT (1) ATE205708T1 (es)
AU (1) AU703310B2 (es)
BR (1) BR9604034A (es)
CA (1) CA2182939C (es)
CZ (1) CZ289167B6 (es)
DE (2) DE19530575A1 (es)
DK (1) DK0759296T3 (es)
ES (1) ES2164198T3 (es)
GR (1) GR3036720T3 (es)
HU (1) HU227360B1 (es)
IL (1) IL119080A (es)
MY (1) MY113908A (es)
NO (1) NO313486B1 (es)
NZ (1) NZ299141A (es)
PE (1) PE8298A1 (es)
PL (1) PL184785B1 (es)
PT (1) PT759296E (es)
RU (1) RU2174837C2 (es)
SI (1) SI0759296T1 (es)
SK (1) SK281779B6 (es)
UA (1) UA41392C2 (es)
UY (1) UY24308A1 (es)
ZA (1) ZA966985B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389752C (zh) * 1978-04-21 2008-05-28 莱博法姆公司 控释组合物
CA2217238C (en) * 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient
NZ507271A (en) * 1998-03-06 2003-03-28 Eurand Internat S Fast disintegrating tablets
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
DE19901686A1 (de) * 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
DE19940944B4 (de) 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
ATE279186T1 (de) 1999-08-31 2004-10-15 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
RU2292877C2 (ru) * 1999-08-31 2007-02-10 Грюненталь Гмбх Лекарственная ретард-форма, содержащая сахаринат трамадола
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
RU2174836C1 (ru) * 2000-12-15 2001-10-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая анальгезирующим действием
CN1942175B (zh) * 2002-10-25 2010-05-26 莱博法姆公司 24小时有效的曲马多缓释制剂
CA2503155A1 (en) * 2002-10-25 2004-05-06 Labopharm Inc. Sustained-release tramadol formulations with 24-hour efficacy
AU2003275854B9 (en) * 2002-10-25 2009-08-27 Paladin Labs (Barbados) Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
ES2737348T3 (es) 2003-09-12 2020-01-13 Amgen Inc Formulación de disolución rápida que comprende cinacalcet HCl
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
ES2255429B1 (es) * 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
SI1931346T1 (sl) 2005-09-09 2012-10-30 Angelini Labopharm Llc Trazodonski sestavek za dajanje enkrat dnevno
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
ITMI20130210A1 (it) 2013-02-14 2014-08-15 Menarini Lab Composizioni farmaceutiche contenenti dexketoprofene e tramadolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3181998A (en) 1960-08-12 1965-05-04 Joseph L Kanig Tablet disintegration
DE1617343B2 (de) 1967-04-21 1976-04-22 CH. Boehringer Sohn, 6507 Ingelheim Traegermasse fuer arzneimitteltabletten
US4517179A (en) 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4600579A (en) 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
EP0272265B1 (de) * 1985-09-25 1991-05-22 Gergely, Gerhard, Dr. Zerfallstablette und verfahren zu ihrer herstellung
CH675537A5 (es) 1988-03-25 1990-10-15 Ciba Geigy Ag
US5211957A (en) * 1988-03-25 1993-05-18 Ciba-Geigy Corporation Solid rapidly disintegrating dosage form
US5254355A (en) 1992-05-29 1993-10-19 Kraft General Foods, Inc. Process for beverage tablets and products therefrom
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung

Also Published As

Publication number Publication date
NO963430D0 (no) 1996-08-16
RU2174837C2 (ru) 2001-10-20
CA2182939C (en) 2007-06-19
BR9604034A (pt) 1998-06-09
SK281779B6 (sk) 2001-07-10
NO313486B1 (no) 2002-10-14
DE59607710D1 (de) 2001-10-25
HK1010100A1 (en) 1999-06-11
JPH09110684A (ja) 1997-04-28
HU9602266D0 (en) 1996-10-28
ATE205708T1 (de) 2001-10-15
PL315749A1 (en) 1997-03-03
SK104296A3 (en) 1997-05-07
NO963430L (no) 1997-02-20
PL184785B1 (pl) 2002-12-31
JP4074675B2 (ja) 2008-04-09
EP0759296B1 (de) 2001-09-19
CN1145780A (zh) 1997-03-26
PT759296E (pt) 2002-03-28
CA2182939A1 (en) 1997-02-20
MX9603140A (es) 1997-07-31
HUP9602266A2 (en) 1997-12-29
AU6194196A (en) 1997-02-27
GR3036720T3 (en) 2001-12-31
DK0759296T3 (da) 2001-11-26
ZA966985B (en) 1997-02-24
IL119080A0 (en) 1996-11-14
US5776492A (en) 1998-07-07
AU703310B2 (en) 1999-03-25
MY113908A (en) 2002-06-30
SI0759296T1 (es) 2001-12-31
CZ289167B6 (cs) 2001-11-14
HUP9602266A3 (en) 1998-10-28
IL119080A (en) 2001-07-24
HU227360B1 (en) 2011-04-28
PE8298A1 (es) 1998-03-28
CZ235996A3 (en) 1997-02-12
UA41392C2 (uk) 2001-09-17
EP0759296A1 (de) 1997-02-26
UY24308A1 (es) 1996-08-27
ES2164198T3 (es) 2002-02-16
NZ299141A (en) 1997-12-19
CN1102385C (zh) 2003-03-05
DE19530575A1 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
AR016827A1 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
ECSP034436A (es) Sales de valsartan
ES2159591T3 (es) Composicion de liberacion controlada.
EP1078628A3 (en) Multiple unit tableted dosage form
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
MXPA03007712A (es) Sales farmaceuticas.
ES533580A0 (es) Un metodo para preaparar una composicion farmaceutica para aplicacion topica que contiene n-(2 hidroxietil)-pirrolidona.
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
UY24436A1 (es) Formulaciones orales de paroxetina de liberación controlada y retardada
ECSP024341A (es) Composiciones farmaceuticas
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
PT839041E (pt) Sais de derivados de amidina e de inibidor de ciclooxigenase processo para a sua preparacao sua utilizacao como farmacos e composicoes farmaceuticas contendo os referidos sais
SE9700885D0 (sv) New pharmaceutical formulation
FI970058L (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
CA2203310A1 (fr) Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale
MA26899A1 (fr) PREPARATIONS CONTENANT UN MEDICAMENT GLUCOCORTICOiDE POUR LE TRAITEMENT DES MALADIES BRONCHOPULMONAIRES.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
DK0748222T3 (da) Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin
SE9501808D0 (sv) New process
NO963796D0 (no) Retard-tablett inneholdende Diclofenac-Na

Legal Events

Date Code Title Description
FC Refusal